Meiqian Li
-
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 5
- RNA modifications and cancer 1
-
- Urinary Bladder and Prostate Research 2
-
- Bladder and Urothelial Cancer Treatments 4
-
- Hormonal and reproductive studies 2
-
- Ferroptosis and cancer prognosis 2
-
- Optimization and Mathematical Programming 1
- Journals
- Journal of Biological Chemistry (1 paper)Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Meiqian Li
12 papers receiving 404 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 126
- Molecular Biology 294
- Urology 19
- Molecular Medicine 14
- Immunology 54
Countries citing papers authored by Meiqian Li
This map shows the geographic impact of Meiqian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqian Li more than expected).
Fields of papers citing papers by Meiqian Li
This network shows the impact of papers produced by Meiqian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqian Li. The network helps show where Meiqian Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meiqian Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistancebreakdown → | 2023 | 96 |
| 3 | 2023 | 6 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 39 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 49 | |
| 11 | 2018 | 91 | |
| 12 | 2014 | 46 |
About Meiqian Li
Meiqian Li is a scholar working on Urology, Hepatology and Statistics and Probability, having authored 12 papers that have together received 407 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Cancer-related gene regulation (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Hormonal and reproductive studies (2 papers), Urinary Bladder and Prostate Research (2 papers), Ferroptosis and cancer prognosis (2 papers), RNA modifications and cancer (1 paper) and Optimization and Mathematical Programming (1 paper). The work is most often cited by research in Cancer Research (126 citations), Molecular Biology (294 citations) and Urology (19 citations). Meiqian Li has collaborated with scholars based in China and United States. Frequent co-authors include Ruimin Huang, Jun Yan, Hongqian Guo, Junlong Zhuang, Jingya Sun, Dong Yu, Zhen Zhu, Bing Shen, Dianzheng Zhang and Hongwen Zhu. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.